Ensysce Biosciences has announced a significant amendment to its bylaws, effective November 1, 2024, that will lower the quorum requirement for stockholder meetings. The amendment reduces the number of shares needed to constitute a quorum from a majority to one-third of the total votes entitled to be cast.This strategic change in corporate governance structure, approved on October 17, 2024, aims to facilitate more efficient stockholder meetings by making it easier to achieve the necessary quorum for conducting business. The amendment was formally disclosed through an SEC Form 8-K filing on October 18, 2024.

Ensysce Biosciences has announced a significant amendment to its bylaws, effective November 1, 2024, that will lower the quorum requirement for stockholder meetings. The amendment reduces the number of shares needed to constitute a quorum from a majority to one-third of the total votes entitled to be cast.This strategic change in corporate governance structure, approved on October 17, 2024, aims to facilitate more efficient stockholder meetings by making it easier to achieve the necessary quorum for conducting business. The amendment was formally disclosed through an SEC Form 8-K filing on October 18, 2024.